
Ritivel YC Application
Ritivel went through Y Combinator in the Winter 2026 batch as a Healthcare company. Below: what the company does, who founded it, and its application to YC, reconstructed question by question in the real YC form.
- YC batch
- Winter 2026
- Industry
- HealthcareHealthcare IT
- Team size
- 3
- Status
- Active
- Launched
- 2026
Founders
Nirmit AroraFounder
Gunin GuptaFounder
Pavan Kalyan (a.k.a PK) TankalaFounder
What Ritivel does
Ritivel is an AI-native workspace for regulatory and medical writing teams at life sciences companies. Our AI agents draft CTDs, CSRs, INDs, and BLAs in minutes instead of weeks, helping drugs reach patients faster. Every month a drug is delayed from reaching the market costs pharma companies ~$45M in lost revenue and more importantly, delays treatment for thousands of patients who need it. Yet regulatory teams are stuck in a painful, months-long process: synthesizing thousands of pages of clinical data, hunting through SharePoint folders for the right documents, chasing colleagues for missing inputs, and manually drafting submissions. Ritivel deploys AI agents that transform how regulatory teams work. Our agents generate comprehensive first drafts directly in Microsoft Word, following FDA formatting requirements and pulling from your existing clinical data and prior submissions. Every data point includes citations linked back to the original source, so reviewers can verify with one click. Connected to SharePoint and Veeva, our agents automatically source the right documents. Integrated with Outlook, they handle reminder emails and follow-ups automatically. We're engineers who previously built AI copilots at Microsoft Research. After 50+ conversations with pharma professionals, we discovered the critical bottleneck in regulatory submissions and built Ritivel to solve it.
Ritivel's YC application, reconstructed
Y Combinator application
Ritivel, Winter 2026 batch. The real form questions, answered from public data.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Ritivel
AI-native platform for Life-Sciences Documentation
We built an AI-native workspace specifically for regulatory and medical writing teams in life sciences. Our AI agents generate first drafts of CTDs, CSRs, INDs, and BLAs within minutes, following FDA formatting and citing original data sources. They integrate with SharePoint, Veeva, and Outlook to pull documents, automate follow-ups, and simplify weeks-long manual processes into a matter of hours.
We live in San Francisco and plan to keep the company based here after YC as well.
San Francisco is where we live and where our target enterprise clients and partners are concentrated. Being here keeps us close to pharma and biotech hubs and lets us recruit the talent we need to build complex AI tools for regulatory documentation.
21 more answers in the full application
Founders, Progress, Idea, Equity, Curious, Batch Preference are in the full version. Create a free account to open it in YC Insights, next to every other YC batch.
Frequently Asked Questions
Is this the real Ritivel YC application?
No. Y Combinator keeps submitted applications private. This is a reconstruction: the real YC form questions, answered from Ritivel's public data (launch notes, founder backgrounds, product description). It shows how a company like Ritivel would present itself to YC, not the text they submitted.
What YC batch was Ritivel in?
Ritivel was part of the Y Combinator Winter 2026 batch.
Who founded Ritivel?
Ritivel was founded by Nirmit Arora, Gunin Gupta, Pavan Kalyan (a.k.a PK) Tankala.
What does Ritivel do?
AI-native platform for Life-Sciences Documentation
How do I read the full reconstructed application?
Create a free Round Funded account. The full 26-answer version of Ritivel's application, and every other YC batch, is in YC Insights.